Canada Pension Plan Investment Board
CRBP icon

Canada Pension Plan Investment Board’s Corbus Pharmaceuticals CRBP Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Buy
+12,400
New +$104K ﹤0.01% 1643
2024
Q4 		– Sell
-26,000
Closed -$536K – 1425
2024
Q3 		$536K Buy
+26,000
New +$1.33M ﹤0.01% 1040

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Canada Pension Plan Investment Board's CRBP Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 12,400 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #1643 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in CRBP as recently as Q3 2024.

Canada Pension Plan Investment Board first reported a position in CRBP in Q3 2024 and has held it in 2 quarters since. The position peaked at $536K in Q3 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Canada Pension Plan Investment Board held 12,400 shares of Corbus Pharmaceuticals worth $116K as of Q1 2026.
  • Corbus Pharmaceuticals was a new Canada Pension Plan Investment Board position in Q1 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1643 holding.
  • Canada Pension Plan Investment Board first reported a position in Corbus Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • Canada Pension Plan Investment Board's Corbus Pharmaceuticals position peaked at $536K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.